References
- Bogoyevitch MA: An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc Res 63: 208, 2004 https://doi.org/10.1016/j.cardiores.2004.03.017
- Shi Y, Rafiee P, Su J, Pritchard KA Jr, Tweddell JS, Baker JE: Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. Basic Res Cardiol 99: 173, 2004 https://doi.org/10.1007/s00395-004-0455-x
- Moon C Krawczyk M, Ahn D, Ahmet I, Paik D, Lakatta EG, Talan MI: Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 100: 11612, 2003
- Parsa CJ, Kim J, Riel RU, Pascal LS, Thompson RB, Petrofski JA, Matsumoto A, Stamler JS, Koch WJ: Cardiaprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Bioi Chem 279: 20655, 2004 https://doi.org/10.1074/jbc.M314099200
- Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK Britti D, Yaqoob MM, Thiemermann C: Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 66: 983, 2004 https://doi.org/10.1111/j.1523-1755.2004.00847.x
- Haroon ZA, Amin K Jiang X, Arcasoy MO: A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 163: 993, 2003 https://doi.org/10.1016/S0002-9440(10)63459-1
- Saray A, Ozakpinar R, Koc C Serel S, Sen Z, Can Z: Effect of chronic and short-term erythropoietin treatment on random flap survival in rats: an experimental study. Laryngoscope 113: 85, 2003 https://doi.org/10.1097/00005537-200301000-00016
- Bradford MM: A rapid and sensitive for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248, 1976 https://doi.org/10.1016/0003-2697(76)90527-3
- Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C Saitta A, Caputi AP: Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 127: 482, 1999
- Rafiee P, Shi Y, Su J, Pritchard KA Jr, Tweddell JS, Baker JE: Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol 100: 187, 2005 https://doi.org/10.1007/s00395-004-0508-1
- Santhanam AV, Smith LA, Akiyama M, Rosales AG, Bailey KR, Katusic ZS: Role of endothelial NO synthase phosphorylation in cerebrovascular protective effect of recombinant erythropoietin during subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 36: 2731, 2005 https://doi.org/10.1161/01.STR.0000190021.85035.5b
- Jaquet K Krause K Tawakol-Khodai M, Geidel S, Kuck KH: Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 64: 326, 2002 https://doi.org/10.1006/mvre.2002.2426
- Buemi M, Galeano M, Sturiale A, Ientile R, Crisafulli C Parisi A, Catania M, Calapai G, Impala P, Aloisi C Squadrito F, Altavilla D, Bitto A, Tuccari G, Frisina N: Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds. Shock 22: 169, 2004 https://doi.org/10.1097/01.shk.0000133591.47776.bd
- Galeano M, Altavilla D, Cucinotta D, Russo GT, Calo M, Bitto A, Marini H, Marini R, Adamo EB, Seminara P, Minutoli L, Torre V, Squadrito F: Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 53: 2509, 2004 https://doi.org/10.2337/diabetes.53.9.2509
- Bor-Kucukatay M, Yalcin O, Meiselman HJ, Baskurt OK: Erythropoietin-induced rheological changes of rat erythrocytes. Br J Haemaiol 110: 82, 2000 https://doi.org/10.1046/j.1365-2141.2000.02150.x